Images: Related links to external sites (from Bing)
Ontology:
infliximab
(C0666743)
Definition (CHV)
|
a drug used to treat autoimmune disorders
|
Definition (CHV)
|
a drug used to treat autoimmune disorders
|
Definition (NCI_NCI-GLOSS)
|
A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies.
|
Definition (NCI)
|
A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis. Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. (NCI04)
|
Definition (PDQ)
|
A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis. Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38698&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38698&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1789" NCI Thesaurus)
|
Concepts |
Amino Acid, Peptide, or Protein
(T116)
, Immunologic Factor
(T129)
, Pharmacologic Substance
(T121)
|
MSH |
C108577
|
SnomedCT |
108675009, 386891004 |
LNC |
LP35095-6, MTHU018219 |
English |
infliximab (medication), monoclonal antibody cA2, MAb cA2, tumor necrosis factor alpha blockers infliximab, infliximab, infliximab [Chemical/Ingredient], monoclonal antibody ca2, inFLIXimab, Infliximab (product), Infliximab (substance), Infliximab, INFLIX, INF, cA2, INFLIXIMAB |
Spanish |
infliximab (producto), infliximab (sustancia), infliximab |
Ontology:
Remicade
(C0723012)
Definition (CHV)
|
brand name of infliximab a drug used to treat autoimmune disorders
|
Definition (CHV)
|
brand name of infliximab a drug used to treat autoimmune disorders
|
Concepts |
Pharmacologic Substance
(T121)
, Amino Acid, Peptide, or Protein
(T116)
, Immunologic Factor
(T129)
|
MSH |
C108577
|
LNC |
LA16782-7 |
English |
Remicade [brand name], Remicade, Centocor brand of infliximab, Essex brand of infliximab, Schering brand of infliximab, Schering-Plough brand of infliximab |